Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2014, Article ID 821894, 5 pages
http://dx.doi.org/10.1155/2014/821894
Clinical Study

Dementia Coding, Workup, and Treatment in the VA New England Healthcare System

1Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA, USA
2Division of Aging, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, 150 S. Huntington Avenue, Boston, MA 02130, USA
3Boston University School of Public Health, Boston, MA, USA
4New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA, USA
5United BioSource Corporation, Lexington, MA, USA

Received 19 April 2013; Accepted 20 December 2013; Published 19 February 2014

Academic Editor: Francesco Panza

Copyright © 2014 Kelly Cho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Alzheimer's Association, “Alzheimer's disease facts and figures,” Tech. Rep., 2011. View at Google Scholar
  2. L. L. Krishnan, N. J. Petersen, A. L. Snow et al., “Prevalence of dementia among veterans affairs medical care system users,” Dementia and Geriatric Cognitive Disorders, vol. 20, no. 4, pp. 245–253, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. C. M. Callahan, H. C. Hendrie, and W. M. Tierney, “Documentation and evaluation of cognitive impairment in elderly primary care patients,” Annals of Internal Medicine, vol. 122, no. 6, pp. 422–429, 1995. View at Google Scholar · View at Scopus
  4. J. Chodosh, D. B. Petitti, M. Elliott et al., “Physician recognition of cognitive impairment: evaluating the need for improvement,” Journal of the American Geriatrics Society, vol. 52, no. 7, pp. 1051–1059, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. R. C. Petersen, J. C. Stevens, M. Ganguli, E. G. Tangalos, J. L. Cummings, and S. T. DeKosky, “Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology,” Neurology, vol. 56, pp. 1133–1142, 2001. View at Google Scholar
  6. L. J. Fitten, K. M. Perryman, C. J. Wilkinson et al., “Alzheimer and vascular dementias and driving: a prospective road and laboratory study,” The Journal of the American Medical Association, vol. 273, no. 17, pp. 1360–1365, 1995. View at Google Scholar · View at Scopus
  7. J.-M. Orgogozo, G. W. Small, G. Hammond, B. Van Baelen, and S. Schwalen, “Effects of galantamine in patients with mild Alzheimer's disease,” Current Medical Research and Opinion, vol. 20, no. 11, pp. 1815–1820, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Seltzer, P. Zolnouni, M. Nunez et al., “Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial,” Archives of Neurology, vol. 61, no. 12, pp. 1852–1856, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Mitchell, N. Meader, and M. Pentzek, “Clinical recognition of dementia and cognitive impairment in primary care: a meta-analysis of physician accuracy,” Acta Psychiatrica Scandinavica, vol. 124, no. 3, pp. 165–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Bradford, M. E. Kunik, P. Schulz, S. P. Williams, and H. Singh, “Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors,” Alzheimer Disease and Associated Disorders, vol. 23, no. 4, pp. 306–314, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. T. K. T. Phung, B. B. Andersen, P. Høgh, L. V. Kessing, P. B. Mortensen, and G. Waldemar, “Validity of dementia diagnoses in the Danish hospital registers,” Dementia and Geriatric Cognitive Disorders, vol. 24, no. 3, pp. 220–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Koch and S. Iliffe, “Rapid appraisal of barriers to the diagnosis and management of patients with dementia in primary care: a systematic review,” BMC Family Practice, vol. 11, article 52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. J. Caselli and E. M. Reiman, “Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention,” Journal of Alzheimer's Disease, vol. 33, pp. S405–S416, 2013. View at Google Scholar
  14. D. A. Snowdon, “Healthy aging and dementia: findings from the nun study,” Annals of Internal Medicine, vol. 139, no. 5, pp. 450–454, 2003. View at Google Scholar · View at Scopus
  15. E. H. Corder, A. M. Saunders, W. J. Strittmatter et al., “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families,” Science, vol. 261, no. 5123, pp. 921–923, 1993. View at Google Scholar · View at Scopus
  16. A. M. Saunders, W. J. Strittmatter, D. Schmechel et al., “Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease,” Neurology, vol. 43, no. 8, pp. 1467–1472, 1993. View at Google Scholar · View at Scopus
  17. K. S. Judge, D. M. Bass, A. L. Snow et al., “Partners in dementia care: a care coordination intervention for individuals with dementia and their family caregivers,” Gerontologist, vol. 51, no. 2, pp. 261–272, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. McCarten, P. Anderson, K. MA, Y. Jonk, and M. Dysken, “Changes in outpatient costs following screening and diagnosis of cognitive impairment,” Alzheimer's & Dementia, vol. 6, no. 4, supplement, p. e19, 2010. View at Google Scholar
  19. I. McKeith, T. Del Ser, P. Spano et al., “Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study,” The Lancet, vol. 356, no. 9247, pp. 2031–2036, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. “Updated criteria for use: cholinesterase inhibitors and memantine to treat dementia,” 2008, http://www.pbm.va.gov/clinicalguidance/criteriaforuse/CholinesteraseInhibitorsCriteriaforUseUpdated73108.doc.
  21. G. A. Kerchner, M. C. Tartaglia, and A. L. Boxer, “Abhorring the vacuum: use of Alzheimer's disease medications in frontotemporal dementia,” Expert Review of Neurotherapeutics, vol. 11, no. 5, pp. 709–717, 2011. View at Publisher · View at Google Scholar · View at Scopus